BMC Infectious Diseases (Jan 2022)

Characteristics associated with HIV and hepatitis C seroprevalence among sexual and injecting partners of HIV positive persons who inject drugs in Nairobi and coastal Kenya

  • Betsy C. Sambai,
  • Hanley Kingston,
  • Aliza Monroe-Wise,
  • Loice Mbogo,
  • Emily Juma,
  • Natasha Ludwig-Barron,
  • Brandon L. Guthrie,
  • David Bukusi,
  • Bhavna H. Chohan,
  • John Scott,
  • Rose Bosire,
  • Matthew Dunbar,
  • Paul Macharia,
  • Sarah Masyuko,
  • William Sinkele,
  • Joshua T. Herbeck,
  • Carey Farquhar

DOI
https://doi.org/10.1186/s12879-022-07036-8
Journal volume & issue
Vol. 22, no. 1
pp. 1 – 15

Abstract

Read online

Abstract Background Persons who inject drugs (PWID) have higher HIV and hepatitis C virus (HCV) seroprevalence than the general population in many parts of sub-Saharan Africa (SSA). The seroprevalences of HIV and HCV are also higher in coastal Kenya than in Nairobi. Understanding drivers of regional HIV and HCV variation among PWID in Kenya may inform population-specific prevention interventions. Methods Using a cross-sectional study, we defined HIV and HCV seroprevalence among persons identified as sexual or injecting partners of HIV positive PWID in two regions of Kenya and used logistic regression to identify demographic and behavioral characteristics associated with higher seroprevalence. Results Among 2386 partners, 469 (19.7%) tested HIV positive and 297(12.4%) tested HCV antibody positive. Partners on the Coast were more likely to live with HIV (seroprevalences: Coast = 23.8%, Nairobi = 17.1%; p 12 times greater than is reported among the general population in Kenya (4% and < 1%, respectively). Providing resources and education will be crucial to reduce exposure and to maintain the lower needle and equipment sharing that we observed compared to other studies.

Keywords